Focusing on boron in medicinal chemistry

Future Medicinal Chemistry

Volumn 5, Issue 6, 2013, Pages 611-612

  Ramachandran, P Veeraraghavan ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 CARBORANYLTHYMIDINE DERIVATIVE; ALPHA METHYL GAMMA BUTYROLACTONE DERIVATIVE; BENZOXABOROLE DERIVATIVE; BORON DERIVATIVE; BORTEZOMIB; NANOMATERIAL; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEASOME INHIBITOR; THYMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; CHEMICAL COMPOSITION; CHEMICAL REACTION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; DRUG SYNTHESIS; EDITORIAL; HUMAN; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; BORONIC ACIDS; CHEMISTRY, PHARMACEUTICAL; HUMANS; MULTIPLE MYELOMA; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES;

EID: 84876871926     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.13.60     Document Type: Editorial

References (28)

1. Organic Syntheses via Boranes, Volume 2: Recent Developments. Brown HC, Zaidlewicz M (Eds). Aldrich Chemical Co., WI, USA (2001
2. Hawthorne MF. Interview with M Frederick Hawthorne. Future Med. Chem. 5(6), 627-632 (2013
3. Dembitsky VM, Smoum R, Al-Quntar AA, Ali HA, Pergament I, Srebnik M. Natural occurrence of boron-containing compounds in plants, algae and microorganisms. Plant Sci. 163, 931-942 (2002
4. Stock A. Hydrides of Boron and Silicon. Cornell University Press, NY, USA (1933
5. Schlesinger HI, Brown HC, Abraham B et al. New developments in the chemistry of diborane and the borohydrides. 1. General summary. J. Am. Chem. Soc. 75, 186-190 (1953
6. Brown HC, Rao BCS. A new technique for the conversion of olefins into organoboranes and related alcohols. J. Am. Chem. Soc. 78, 5694-5695 (1956
7. Ishiyama T, Takagi J, Ishida K, Miyaura N, Anastasi NR, Hartwig JF. Mild iridium-catalyzed borylation of arenes. High turnover numbers, room temperature reactions, and isolation of a potential intermediate. J. Am. Chem. Soc. 124, 390-391 (2002
8. Miyaura M, Suzuki A. Palladium-catalyzed cross coupling reactions of organoboron compounds. Chem. Rev. 95, 2457-2483 (1995
9. Kane RC, Bross PF, Farrell AT, Pazdur R. Velcade: US FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologist 8, 508-513 (2003
10. Yang W, Gao X, Wang B. Boronic acid compounds as potential pharmaceutical agents. Med. Res. Rev. 23, 346-368 (2003
11. Dembitsky VM, Quntar AAAA, Srebnik M. Natural and synthetic small boron-containing molecules as potential inhibitors of bacterial and fungal quorum sensing. Chem. Rev. 111, 209-237 (2011
12. Tomsho JW, Pal A, Hall DG, Benkovic SJ. Ring structure and aromatic substituent effects on the pKa of the benzoxaborole pharmacophore. Med. Chem. Lett. 3, 48-52 (2012
13. Qiao Z, Wang Q, Zhang F et al. Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents. J. Med. Chem. 55, 3553-3557 (2012
14. Adamczyk-Wozniak A, Komarovska- Porokhnyavets O, Misterkiewicz B, Novikov VP, Sporzynski A. Biological activity of selected boronic acids and their derivatives. Appl. Organomet. Chem. 26, 390-393 (2012
15. Cordes DB, Singaram B. A unique, two-component sensing system for fluorescence detection of glucose and other carbohydrates. Pure Appl. Chem. 84, 2183-2202 (2012
16. Li XF, Zhang YK, Plattner JJ et al. Synthesis and antibacterial evaluation of a novel tricyclic oxaborole-fused fluoroquinolone. Bioorg. Med. Chem. Lett. 23, 963-966 (2013
17. Baker SJ, Ding CZ, Akama T, Zhang YK, Hernandez V, Xia Y. Therapeutic potential of boron-containing compounds. Future Med. Chem. 1, 1275-1288 (2009
18. Jacobs RT, Plattner JJ, Nare B et al. Benzoxaboroles: A new class of potential drugs for human African trypanosomiasis. Future Med. Chem. 3, 1259-1278 (2011
19. Nakamura H. Boron lipid-based liposomal boron delivery system for neutron capture therapy - recent development and future perspective. Future Med. Chem. 5(6), 715-730 (2013
20. Marepally SR, Yao ML, Kabalka GW. Boron lipid-based liposomal boron delivery system for neutron capture therapy: Recent development and future perspective. Future Med. Chem. 5(6), 693-704 (2013
21. Khalil A, Ishita K, Ali T, Tjarks W. N3- substituted thymidine bioconjugates for cancer therapy and imaging. Future Med. Chem. 5(6), 677-692 (2013
22. Yinghuai Z, Hosmane NS. Applications and perspectives of boron-enriched nanocomposites in cancer therapy. Future Med. Chem. 5(6), 705-714 (2013
23. Das BC, Thapa P, Karki R et al. Boron chemicals in diagnosis and therapeutics. Future Med. Chem. 5(6), 653-676 (2013
24. Ramachandran PV, Nicponski DR, Drolet MP, Schmidt CM, Yip-Schneider MT. The first synthesis of a borylated a-methylene-g-butyrolactone. Future Med. Chem. 5(6), 633-639 (2013
25. SS Printsevskaya1, MI Reznikova1, AM Korolev et al. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles. Future Med. Chem. 5(6), 641-652 (2013
26. Ahmet JT, Spencer J. Boron medicinal chemistry and synthetic aspects. Future Med. Chem. 5(6), 621-622 (2013
27. Viñas i Teixidor C. The uniqueness of boron as a novel challenging element for drugs in pharmacology, medicine and for smart biomaterials. Future Med. Chem. 5(6), 617-619 (2013
28. Westcott SA. Hot peppers for a healthier future: Boron-containing capsaicinoids. Future Med. Chem. 5(6), 613-615 (2013